BLUEGRASS EYE BUILDING OFFICE LEASE AGREEMENT BY AND BETWEEN DHB PROPERTIES. LLC, A KENTUCKY PROFESSIONAL SERVICE CORPORATION (“LANDLORD”) AND APELLIS PHARMACUTICALS, INC. A DELAWARE CORPORATION (“TENANT”) DATED OCTOBER 21, 2010Office Lease Agreement • August 19th, 2015 • Apellis Pharmaceuticals, Inc. • Pharmaceutical preparations • Kentucky
Contract Type FiledAugust 19th, 2015 Company Industry JurisdictionTHIS OFFICE LEASE AGREEMENT (“Lease”) is entered into and made this day of October, 2010, by and between (i) DHB PROPERTIES, LLC, a Kentucky professional services corporation (“Landlord”), and (ii) APELLIS PHARMACEUTICALS, INC, a Delaware corporation (“Tenant”).
ASSET PURCHASE AGREEMENT dated September 24, 2014 between APELLIS PHARMACEUTICALS, INC. and POTENTIA PHARMACEUTICALS, INC.Asset Purchase Agreement • August 19th, 2015 • Apellis Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 19th, 2015 Company Industry JurisdictionThis Asset Purchase Agreement is entered into as of September 24, 2014 by and between Apellis Pharmaceuticals, Inc., a Delaware corporation (the “Buyer”), and Potentia Pharmaceuticals, Inc., a Delaware corporation (the “Seller”).
INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • August 19th, 2015 • Apellis Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 19th, 2015 Company Industry JurisdictionTHIS INVESTORS’ RIGHTS AGREEMENT is made as of the 30th day of July, 2013, by and among Apellis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, and each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a “Key Holder” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof.